Cargando…
Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice
Histone deacetylase (HDAC) inhibitors are of significant interest as drugs. However, their use to treat neurological disorders has raised concern because HDACs are required for brain function. We have previously shown that a triple combination formulation (TCF) of the pan HDACi vorinostat (Vo), 2-hy...
Autores principales: | Alam, Md. Suhail, Cooper, Bruce, Farris, Joseph D., Haldar, Kasturi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832807/ https://www.ncbi.nlm.nih.gov/pubmed/29497113 http://dx.doi.org/10.1038/s41598-018-22162-7 |
Ejemplares similares
-
Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease
por: Collins, Christopher J., et al.
Publicado: (2017) -
Large scale analyses of genotype-phenotype relationships of glycine decarboxylase mutations and neurological disease severity
por: Farris, Joseph, et al.
Publicado: (2020) -
Genomic analyses of glycine decarboxylase neurogenic mutations yield a large-scale prediction model for prenatal disease
por: Farris, Joseph, et al.
Publicado: (2021) -
Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease
por: Marques, André R. A., et al.
Publicado: (2016) -
Niemann-Pick disease type C
por: Vanier, Marie T
Publicado: (2010)